As of Sep 29
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for SkyePharma PLC have a median target of 6.31, with a high estimate of 7.14 and a low estimate of 5.47. The median estimate represents a +16.80% increase from the last price of 5.40.
The current consensus among 2 polled investment analysts is to Buy stock in SkyePharma PLC. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.